HIGHLIGHTS
SUMMARY
In this context, the introduction of small_molecule immune checkpoints` inhibitors represents a third-generation wave of alternatives to these MABs. Of all immune checkpoints, PD-L1 seems to be the most promising target for small_molecule inhibitors. Two follow-up X-ray structure studies have confirmed the binding mode of these small_molecules onto a groove formed at the interface between two PD-L1 monomers, at their PD-1 binding faces. The authors describe and discuss the results obtained from a detailed in silico structural characterization of five small_molecule organic compounds targeting the PD-L1 protein . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.